BR9508395A - Composto químico preparação do mesmo e uso dele em composições farmacêuticas - Google Patents

Composto químico preparação do mesmo e uso dele em composições farmacêuticas

Info

Publication number
BR9508395A
BR9508395A BR9508395A BR9508395A BR9508395A BR 9508395 A BR9508395 A BR 9508395A BR 9508395 A BR9508395 A BR 9508395A BR 9508395 A BR9508395 A BR 9508395A BR 9508395 A BR9508395 A BR 9508395A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
chemical compound
compound preparation
preparation
chemical
Prior art date
Application number
BR9508395A
Other languages
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of BR9508395A publication Critical patent/BR9508395A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9508395A 1994-07-13 1995-06-03 Composto químico preparação do mesmo e uso dele em composições farmacêuticas BR9508395A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (de) 1994-07-13 1995-06-03 Neue chemische verbindung, ihre herstellung und ihre verwendung als arzneistoff

Publications (1)

Publication Number Publication Date
BR9508395A true BR9508395A (pt) 1997-12-23

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508395A BR9508395A (pt) 1994-07-13 1995-06-03 Composto químico preparação do mesmo e uso dele em composições farmacêuticas

Country Status (25)

Country Link
US (1) US5686496A (pt)
EP (1) EP0770058A1 (pt)
JP (1) JPH10502646A (pt)
KR (1) KR970704674A (pt)
CN (1) CN1152303A (pt)
AU (1) AU2736895A (pt)
BG (1) BG101104A (pt)
BR (1) BR9508395A (pt)
CA (1) CA2194886A1 (pt)
CO (1) CO4410185A1 (pt)
CZ (1) CZ8297A3 (pt)
DE (1) DE4424714A1 (pt)
EE (1) EE9700065A (pt)
FI (1) FI970095A (pt)
HR (1) HRP950363A2 (pt)
HU (1) HUT76827A (pt)
IL (1) IL114572A0 (pt)
MX (1) MX9700245A (pt)
NO (1) NO970123D0 (pt)
PE (1) PE35196A1 (pt)
PL (1) PL318114A1 (pt)
SK (1) SK1897A3 (pt)
WO (1) WO1996002496A1 (pt)
YU (1) YU45395A (pt)
ZA (1) ZA955781B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
EP0743064A1 (en) * 1995-05-17 1996-11-20 Eli Lilly And Company Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
MXPA03006328A (es) * 2001-01-16 2004-04-05 Boehringer Ingelheim Pharma Uso de antagonista de ltb4 para tratamiento y/o prevencion de enfermedades causadas por aumento de expresion de genes de mucina.
CN1658852A (zh) * 2001-08-31 2005-08-24 神经化学（国际）有限公司 用于治疗淀粉样变性的脒衍生物
US20070105104A1 (en) * 2003-05-06 2007-05-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CN1997367B (zh) * 2004-07-05 2010-11-24 同和药品株式会社 预防和治疗过敏性炎症的组合物
US20080206203A1 (en) * 2004-07-14 2008-08-28 Inflammation Research Center Company Ltd. Method for Inhibiting Tumor Metastasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
PT902013E (pt) * 1992-02-05 2002-06-28 Boehringer Ingelheim Pharma Novos derivados amidina sua preparacao e utilizacao como medicamento com actividade antagonista de ltb4

Also Published As

Publication number Publication date
US5686496A (en) 1997-11-11
PL318114A1 (en) 1997-05-12
HUT76827A (en) 1997-11-28
PE35196A1 (es) 1996-09-05
MX9700245A (es) 1997-05-31
HRP950363A2 (en) 1997-08-31
KR970704674A (ko) 1997-09-06
IL114572A0 (en) 1995-11-27
BG101104A (en) 1998-04-30
CN1152303A (zh) 1997-06-18
YU45395A (sh) 1997-12-05
FI970095A0 (fi) 1997-01-10
JPH10502646A (ja) 1998-03-10
CZ8297A3 (en) 1997-09-17
HU9700060D0 (en) 1997-02-28
EE9700065A (et) 1997-08-15
CO4410185A1 (es) 1997-01-09
NO970123L (no) 1997-01-10
SK1897A3 (en) 1997-08-06
EP0770058A1 (de) 1997-05-02
CA2194886A1 (en) 1996-02-01
NO970123D0 (no) 1997-01-10
ZA955781B (en) 1996-02-22
WO1996002496A1 (de) 1996-02-01
FI970095A (fi) 1997-01-10
AU2736895A (en) 1996-02-16
DE4424714A1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
BR9708400A (pt) Composição sua preparação e uso
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
TR199501305A2 (tr) Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi
BR9707501A (pt) Composto composição farmacêutica e uso do composto
BR9202393A (pt) Composicao detergente em particulas alvejante,e,uso de zeolita map
DK0674888T3 (da) Blandeindretning
FI961219A (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
FI950709A (fi) Organometalliset fluorenyyliyhdisteet, valmistus ja käyttö
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
BR9609951A (pt) Novas composições farmacêuticas e seu uso
BR9711191A (pt) Composto e uso do mesmo
BR9508677A (pt) Copolímero prodesso de preparação do mesmo e composição orgânica
BR9707812A (pt) Composto composto farmacêutica e uso do composto
BR9508395A (pt) Composto químico preparação do mesmo e uso dele em composições farmacêuticas
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
BR9610109A (pt) Fecho e uso mesmo
ID21762A (id) Formulasi partikel bersaput
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
BR9707808A (pt) Composto composição farmacêutica e uso do composto
BR9506583A (pt) Composição cosmética e uso da mesma
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
BR9505606A (pt) Formulação herbicidas composição herbecida mista e uso de sulfonilaminofeniluracila substituídas
KR970702890A (ko) 플루오로실리콘 화합물과 이 화합물을 함유하는 조성물(fluorosilicone compound and composition containing the same)
BR9602491A (pt) Misturas uso de misturas e composições de moldagem

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law